Literature DB >> 19165230

Role of HCN4 channel in preventing ventricular arrhythmia.

Kazuo Ueda1, Yuji Hirano, Yasushi Higashiuesato, Yoshiyasu Aizawa, Takeharu Hayashi, Natsuko Inagaki, Takeshi Tana, Yusuke Ohya, Shuichi Takishita, Hiromi Muratani, Masayasu Hiraoka, Akinori Kimura.   

Abstract

Bradycardia is a trigger of ventricular arrhythmias in patients with arrhythmia including Brugada syndrome and long QT syndrome. The HCN4 channel controls the heart rate, and its mutations predispose to inherited sick sinus syndrome and long QT syndrome associated with bradycardia. We found a 4 base-insertion at the splice donor site of the HCN4 gene in a patient with idiopathic ventricular tachycardia, which was supposed to generate a truncated channel. To investigate the role of the HCN4 channel in ventricular arrhythmia, we introduced a ventricular action potential of I(f) channel produced by HCN4 in a computer simulation model and found that the I(f) channel generated a leaky outward current during the plateau phase of ventricular action potential. Currents through the I(f) channel were suggested to contribute to the shortening of the action potential duration and the prevention of early after-depolarization in bradycardia. These observations suggested that the HCN4 channel played a preventive role in triggering bradycardia-induced ventricular arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19165230     DOI: 10.1038/jhg.2008.16

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  31 in total

Review 1.  Genetics of Brugada syndrome.

Authors:  Hiroshi Watanabe; Tohru Minamino
Journal:  J Hum Genet       Date:  2015-07-30       Impact factor: 3.172

Review 2.  Genetic testing for inherited cardiac disease.

Authors:  Arthur A M Wilde; Elijah R Behr
Journal:  Nat Rev Cardiol       Date:  2013-07-30       Impact factor: 32.419

Review 3.  Ion Channels in the Heart.

Authors:  Daniel C Bartos; Eleonora Grandi; Crystal M Ripplinger
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

Review 4.  Interpreting genetic effects through models of cardiac electromechanics.

Authors:  S A Niederer; S Land; S W Omholt; N P Smith
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-10-05       Impact factor: 4.733

5.  Leptin decreases heart rate associated with increased ventricular repolarization via its receptor.

Authors:  Yen-Chang Lin; Jianying Huang; Stan Hileman; Karen H Martin; Robert Hull; Mary Davis; Han-Gang Yu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-25       Impact factor: 4.733

6.  Novel heterozygous mutation c.4282G>T in the SCN5A gene in a family with Brugada syndrome.

Authors:  Jian-Fang Zhu; Li-Li DU; Yuan Tian; Yi-Mei DU; Ling Zhang; Tao Zhou; L I Tian
Journal:  Exp Ther Med       Date:  2015-03-16       Impact factor: 2.447

Review 7.  Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects.

Authors:  Masa-aki Kawashiri; Kenshi Hayashi; Tetsuo Konno; Noboru Fujino; Hidekazu Ino; Masakazu Yamagishi
Journal:  Heart Vessels       Date:  2013-08-02       Impact factor: 2.037

Review 8.  Pathogenesis and management of Brugada syndrome.

Authors:  Juan Sieira; Gregory Dendramis; Pedro Brugada
Journal:  Nat Rev Cardiol       Date:  2016-09-15       Impact factor: 32.419

9.  Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.

Authors:  Lia Crotti; Cherisse A Marcou; David J Tester; Silvia Castelletti; John R Giudicessi; Margherita Torchio; Argelia Medeiros-Domingo; Savastano Simone; Melissa L Will; Federica Dagradi; Peter J Schwartz; Michael J Ackerman
Journal:  J Am Coll Cardiol       Date:  2012-07-25       Impact factor: 24.094

10.  Molecular and functional evidence of HCN4 and caveolin-3 interaction during cardiomyocyte differentiation from human embryonic stem cells.

Authors:  Alexis Bosman; Laura Sartiani; Valentina Spinelli; Martina Del Lungo; Francesca Stillitano; Daniele Nosi; Alessandro Mugelli; Elisabetta Cerbai; Marisa Jaconi
Journal:  Stem Cells Dev       Date:  2013-02-27       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.